Lusay, Reyvin A.

HRN: 09-66-11  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2024
CEFUROXIME 1.5GM (VIAL)
11/07/2024
11/14/2024
IV
1.5G THEN 750 MG
Q8HRS
UTI
Rejected 
11/09/2024
MUPIROCIN 2%, 15G (TUBE)
11/09/2024
11/16/2024
TOPICAL
Apply Thinly On Affected Area
Bid
Abrasion
Waiting Final Action 
11/15/2024
BENZYL PENICILLIN 1MU (VIAL)
11/15/2024
11/21/2024
IV
1.5million Units
Q6h
Acute Glomerulonephritis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: